Robeco Institutional Asset Management B.V. Lowers Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Robeco Institutional Asset Management B.V. cut its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 56.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,836 shares of the company's stock after selling 74,598 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Bath & Body Works were worth $1,846,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. New York State Teachers Retirement System lifted its position in shares of Bath & Body Works by 18.1% in the 3rd quarter. New York State Teachers Retirement System now owns 266,235 shares of the company's stock worth $8,498,000 after purchasing an additional 40,793 shares during the period. Abich Financial Wealth Management LLC acquired a new position in shares of Bath & Body Works in the 3rd quarter worth approximately $103,000. State of Alaska Department of Revenue lifted its position in shares of Bath & Body Works by 418.2% in the 3rd quarter. State of Alaska Department of Revenue now owns 127,226 shares of the company's stock worth $4,061,000 after purchasing an additional 102,675 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Bath & Body Works in the 3rd quarter worth approximately $343,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Bath & Body Works by 69.9% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,092 shares of the company's stock worth $586,000 after purchasing an additional 7,443 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Robert W. Baird lowered their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating for the company in a research note on Thursday, August 29th. Barclays lowered shares of Bath & Body Works from an "equal weight" rating to an "underweight" rating and lowered their price objective for the company from $31.00 to $28.00 in a research note on Friday. Raymond James decreased their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an "outperform" rating for the company in a research note on Thursday, August 29th. Morgan Stanley decreased their price target on shares of Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating for the company in a research note on Thursday, September 5th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Bath & Body Works from $57.00 to $54.00 and set a "buy" rating for the company in a research note on Monday, August 26th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $42.44.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the business's stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company's stock, valued at $7,202,134.68. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.27% of the stock is currently owned by company insiders.

Bath & Body Works Trading Down 5.5 %

Shares of Bath & Body Works stock traded down $1.75 during trading hours on Friday, reaching $30.00. The stock had a trading volume of 9,932,695 shares, compared to its average volume of 4,380,816. The stock's 50 day moving average is $30.01 and its 200 day moving average is $36.87. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The firm has a market capitalization of $6.57 billion, a PE ratio of 7.26, a PEG ratio of 0.95 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.67%. The ex-dividend date is Friday, November 22nd. Bath & Body Works's payout ratio is presently 19.37%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.